Even a brief course of CBT improves TMD treatment outcomes

October 17, 2010

Temporo-mandibular joint dysfunction (TMD) treated with a brief course of cognitive-behavioral therapy (CBT) in addition to standard care improves long-term outcomes, according to a new study published in journal Pain. A group of 101 patients who had pain in TMJ for at least 3 months were included in this study. Standard treatment included splinting, soft diet and an anti-inflammatory drug and was given to all patients. Fifty two patients also received six weekly sessions of cognitive-behavioral therapy. Both those who received standard therapy alone and those who also received CBT improved, however addition of CBT provided additional pain relief, particularly in those people who were open to it and prepared to use it.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe